Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study.
Martínez E, Garin O, Pardo Y, Fernández P, Guix B, Gutiérrez C, Boladeras A, Ferrer F, Hernández T, Ayala A, Egiguren M, Fernández G, Muñoz V, Macías V, Pera J, Pont À, Ferrer M, Guedea F; Multicentric Spanish Group of Clinically Localized Prostate Cancer; Multicentric Spanish Group of Clincally Localized Prostate Cancer: Montse Ferrer, Àngels Pont, Olatz Garin, Yolanda Pardo, Jordi Alonso, Mónica Ávila, Víctor Zamora, Ferran Guedea, Montse Ventura, Cristina Gutiérrez, Ferran Ferrer, Ana Boladeras, José Francisco Suárez, Manel Castells, Xavier Bonet, Pastor S, Carmen Bonet, Gemma Sancho, Javier Ponce de León, Joan Palou, Belén de Paula, Alai Goñi, Pablo Fernández, Ismael Herruzo, Asunción Hervás, Alfredo Ramos, Víctor Macías, Josep Solé, Marta Bonet, Alfonso Mariño, Patricia Cabrera, Maria José Ortiz.
Martínez E, et al. Among authors: guix b.
J Contemp Brachytherapy. 2021 Feb;13(1):1-11. doi: 10.5114/jcb.2021.103580. Epub 2021 Feb 18.
J Contemp Brachytherapy. 2021.
PMID: 34025730
Free PMC article.